Patents by Inventor Edouard Seche

Edouard Seche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW ATTENUATED STRAINS OF APICOMPLEXA AND THEIR USE AS ANTIGEN VECTORS FOR THE PREVENTION OF INFECTIOUS DISEASES
    Publication number: 20210139883
    Abstract: Disclosed is a mutant strain of Sarcocystidae in which the two genes mic1 and mic3 are deleted containing two specific recombination sites of an enzyme allowing a specific recombination, in particular Cre-recombinase, the specific recombination sites being at the respective locus of each of the deleted genes, the specific recombination site of the enzyme allowing specific recombination, in particular of the Cre-recombinase, at the locus of the deleted mic1 gene being different from that of the deleted mic3 gene.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 13, 2021
    Inventors: Anne-France BOUSSEMART-PROUVOST, Edouard SECHE, Thi Kim Chi NGUYEN
  • Methods for freeze-drying and rehydrating biologics
    Patent number: 10632182
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: April 28, 2020
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Novel Methods for Freeze-drying and Rehydrating Biologics
    Publication number: 20170087230
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 30, 2017
    Applicants: MERIAL INC., VITAMFERO S.A, L'Universite De Bourgogne, L'Institut National Superieur des Sciences Agronom iques de L'Alimentation et de L'Environment
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Mutant strains of and uses thereof
    Patent number: 9603914
    Abstract: A mutant strain of Neospora spp, in which the function of the NcMIC3 protein and/or the function of the NcMIC1 protein is suppressed, and uses thereof in a pharmaceutical composition or in a vaccine composition.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: March 28, 2017
    Assignee: VITAMFERO
    Inventors: Anne-France Boussemart-Prouvost, Pascal Breton, Mauld Lamarque, Solen Morisse-Philippe, Edouard Seche
  • Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan
    Patent number: 9585949
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: March 7, 2017
    Assignees: VITAMFERO, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, UNIVERSITE FRANCOIS RABELAIS DE TOURS
    Inventors: Audrey Gnahoui-David, Fabrice Laurent, Marie-Noelle Mevelec, Edouard Seche
  • USE OF ATTENUATED STRAINS OF PARASITES FOR THE PREVENTION OR TREATMENT OF PATHOLOGIES ASSOCIATES WITH AN APICOMPLEXAN
    Publication number: 20160166662
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 16, 2016
    Inventors: Audrey GNAHOUI-DAVID, Fabrice LAURENT, Marie-Noelle MEVELEC, Edouard SECHE
  • USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII
    Publication number: 20160017275
    Abstract: Strains of Toxoplasma gondii isolated from their natural environment for their use in the prevention and/or the treatment, in a mammal, of ocular lesions associated with an infection by an apicomplexan of the Sarcocystidae family.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 21, 2016
    Inventors: Isabelle DIMIER-POISSON, Gildas LEMEE, Solen MORISSE, Edouard SECHE, Naoual TARFAOUI, Emre YURDUSEV
  • MUTANT STRAINS OF NEOSPORA AND USES THEREOF
    Publication number: 20150190487
    Abstract: A mutant strain of Neospora spp, in which the function of the NcMIC3 protein and/or the function of the NcMIC1 protein is suppressed, and uses thereof in a pharmaceutical composition or in a vaccine composition.
    Type: Application
    Filed: August 2, 2013
    Publication date: July 9, 2015
    Inventors: Anne-France Boussemart-Prouvost, Pascal Breton, Mauld Lamarque, Solen Morisse-Philippe, Edouard Seche
  • USE OF ATTENUATED STRAINS OF PARASITES FOR THE PREVENTION OR TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN APICOMPLEXAN
    Publication number: 20150165008
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Application
    Filed: August 2, 2013
    Publication date: June 18, 2015
    Inventors: Audrey Gnahoui-David, Fabrice Laurent, Marie-Noelle Mevelec, Edouard Seche